天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

ChemicalBook >> journal list >> Journal of Antibiotics >>article
Journal of Antibiotics

Journal of Antibiotics

IF: 2.1
Download PDF

Rifaximin: beyond the traditional antibiotic activity

Published:6 August 2014 DOI: 10.1038/ja.2014.106 PMID: 25095806
Fiorella Calanni, Cecilia Renzulli, Miriam Barbanti, Giuseppe Claudio Viscomi

Abstract

Rifaximin is a non-systemic oral antibiotic derived from rifampin and characterized by a broad spectrum of antibacterial activity against Gram-positive and -negative, aerobic and anaerobic bacteria. Rifaximin was first approved in Italy in 1987 and afterwards in many other worldwide countries for the treatment of several gastrointestinal diseases. This review updates the pharmacology and pharmacodynamics of rifaximin highlighting the different actions, beyond its antibacterial activity, such as alteration of virulence, prevention of gut mucosal adherence and bacterial translocation. Moreover, rifaximin exerts some anti-inflammatory effects with only a minimal effect on the overall composition of the gut microbiota. All these properties make rifaximin a good candidate to treat various gastrointestinal diseases.

Substances (2)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Rifampicin 13292-46-1 C43H58N4O12 634 suppliers $15.00-$2020.00
Rifaximin 80621-81-4 C43H51N3O11 497 suppliers $39.00-$1200.00

Similar articles

IF:40.4

Amide bond formation: beyond the myth of coupling reagents

Chemical Society Reviews Eric Valeur and Mark Bradley,etc Published: 4 December 2008
IF:14.7

Benzimidazole and its derivatives as cancer therapeutics: The potential role from traditional to precision medicine

Acta Pharmaceutica Sinica. B Yeuan Ting Lee, Yi Jer Tan,etc Published: 1 February 2023